Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.34 |
| ▸ | NPY4R | P50391 | 10/20 | 0.34 |
| ▸ | NPY1R | P25929 | 7/20 | 0.34 |
| ▸ | NPY2R | P49146 | 5/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9924206 | 1.00 | C3AR1 (0.34) | C3AR1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL2485111 | 0.87 | C3AR1 (0.35) | C3AR1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL23296534 | 0.87 | C3AR1 (0.35) | C3AR1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL2480993 | 0.87 | GPR84 (0.43) | NOD1FOLH1TLR2 | |
| SCHEMBL27859409 | 0.87 | GPR84 (0.43) | NOD1FOLH1TLR2 | |
| Hydrochloric Acid SCHEMBL28862380 | 0.86 | C3AR1 (0.34) | C3AR1NPY4RNPY1RNPY2RNPY5R | |
| Hydrochloric Acid SCHEMBL6546097 | 0.86 | GPR84 (0.42) | NOD1TLR2 | |
| Hydrochloric Acid SCHEMBL27456313 | 0.86 | GPR84 (0.42) | NOD1TLR2 | |
| Hydrochloric Acid SCHEMBL7111708 | 0.86 | GPR84 (0.42) | NOD1TLR2 | |
| Hydrochloric Acid SCHEMBL27454617 | 0.86 | GPR84 (0.42) | NOD1TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102256936-B | Arginine derivative and cosmetic comprising same | NOF CORP | 2014-06-18 | — | — | CN | disclosed |
| EP-2377848-B1 | ARGININE DERIVATIVE AND COSMETIC COMPRISING SAME | NOF CORP (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-8518994-B2 | Arginine derivative and cosmetic containing the same | NOF CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| CN-102256936-A | Arginine derivative and cosmetic comprising same | NOF CORP | 2011-11-23 | — | — | CN | disclosed |
| EP-2377848-A1 | ARGININE DERIVATIVE AND COSMETIC COMPRISING SAME | NOF Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20110245344-A1 | ARGININE DERIVATIVE AND COSMETIC CONTAINING THE SAME | NOF CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245344-A1 | ARGININE DERIVATIVE AND COSMETIC CONTAINING THE SAME | ARG1, ARG2, ARGLU1 | C3AR1 173/4885NPY4R 1138/4885NPY1R 284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.